Genetic influences on blood lipids and cardiovascular disease risk: tools for primary prevention

被引:50
|
作者
Ordovas, Jose M. [1 ]
机构
[1] Tufts Univ, Nutr & Genom Lab, USDA, Human Nutr Ctr Aging, 711 Washington St, Boston, MA 02111 USA
来源
关键词
APOLIPOPROTEIN-E POLYMORPHISM; POSTPRANDIAL LIPOPROTEIN METABOLISM; PROMOTER -219G/T POLYMORPHISM; HEALTH OUTCOMES IMPLICATIONS; ACTIVATED-RECEPTOR-GAMMA; FAT DIETARY PATTERN; SERUM-LIPIDS; E PHENOTYPE; E GENOTYPE; PLASMA-LIPIDS;
D O I
10.3945/ajcn.2009.27113E
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Genetic polymorphism in human populations is part of the evolutionary process that results from the interaction between the environment and the human genome. Recent changes in diet have upset this equilibrium, potentially influencing the risk of most common morbidities such as cardiovascular diseases, obesity, diabetes, and cancer. Reduction of these conditions is a major public health concern, and such a reduction could be achieved by improving our ability to detect disease predisposition early in life and by providing more personalized behavioral recommendations for successful primary prevention. In terms of cardiovascular diseases, polymorphisms at multiple genes have been associated with differential effects in terms of lipid metabolism; however, the connection with cardiovascular disease has been more elusive, and considerable heterogeneity exists among studies regarding the predictive value of genetic markers. This may be because of experimental limitations, the intrinsic complexity of the phenotypes, and the aforementioned interactions with environmental factors. The integration of genetic and environmental complexity into current and future research will drive the field toward the implementation of clinical tools aimed at providing dietary advice optimized for the individual's genome. This may imply that dietary changes are implemented early in life to gain maximum benefit. However, it is important to highlight that most reported studies have focused on adult populations and to extrapolate these findings to children and adolescents may not be justified until proper studies have been carried out in these populations and until the ethical and legal issues associated with this new field are adequately addressed. Am J Clin Nutr 2009; 89(suppl): 1509S-17S.
引用
收藏
页码:S1509 / S1517
页数:9
相关论文
共 50 条
  • [1] Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease
    Robson, J.
    HEART, 2008, 94 (10) : 1331 - 1332
  • [3] Comparison of cardiovascular disease risk assessment tools in primary prevention patients with raised lipoprotein(a)
    Carlton, H. C.
    Banerjee, A.
    Burnett, D.
    Shipman, K. E.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [4] Genetic Risk Prediction for Primary and Secondary Prevention of Atherosclerotic Cardiovascular Disease: an Update
    Christopher Labos
    George Thanassoulis
    Current Cardiology Reports, 2018, 20
  • [5] Genetic Risk Prediction for Primary and Secondary Prevention of Atherosclerotic Cardiovascular Disease: an Update
    Labos, Christopher
    Thanassoulis, George
    CURRENT CARDIOLOGY REPORTS, 2018, 20 (05)
  • [6] Risk functions and the primary prevention of cardiovascular disease
    Grau, Maria
    Marrugat, Jaume
    REVISTA ESPANOLA DE CARDIOLOGIA, 2008, 61 (04): : 404 - 416
  • [7] Risk scoring for the primary prevention of cardiovascular disease
    Karmali, Kunal N.
    Persell, Stephen D.
    Perel, Pablo
    Lloyd-Jones, Donald M.
    Berendsen, Mark A.
    Huffman, Mark D.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (03):
  • [8] Management of lipids and blood pressure for primary prevention of cardiovascular disease in the UK: results from the EURIKA study
    Moschonas, K.
    Godfrey, E.
    Johns, I.
    Ossei-Gerning, N.
    Kassianos, G.
    Halcox, J. P.
    EUROPEAN HEART JOURNAL, 2013, 34 : 164 - 164
  • [9] ANTIHYPERTENSIVE THERAPY AND LIPIDS - PARADOXICAL INFLUENCES ON CARDIOVASCULAR-DISEASE RISK
    WEINBERGER, MH
    AMERICAN JOURNAL OF MEDICINE, 1986, 80 (2A): : 64 - 70
  • [10] The development and prevention of cardiovascular disease risk factors: Socioenvironmental influences
    Terris, M
    JOURNAL OF PUBLIC HEALTH POLICY, 1996, 17 (04) : 426 - 441